Immunoglobulin Therapy by Entera Health Eases IBD Symptoms

Immunoglobulin Therapy by Entera Health Eases IBD Symptoms

Immunoglobulin Therapy for IBDKey representatives of biotechnology company Entera Health, Inc. were recently invited to attend this year's Crohn’s & Colitis Foundation’s Clinical & Research Conference titled, "Advances In Inflammatory Bowel Diseases" in Orlando, FL. Dr. Larry Good of the State University of New York presented two posters, while Dr. Abigail Henderson from Cary, North Carolina, presented a third on Entera's lead therapeutic candidate for IBD.

The first poster, presented by Dr. Good, detailed the findings from a retrospective study on prescription medical food, EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI), involving three patients with ulcerative colitis (UC). Each patient reported having chronic loose and frequent bowel movements along with other common symptoms of UC, and had previously received traditional treatment for their condition, but did not respond favorably. They received 5g of EnteraGam™ daily, which caused a significant improvement or total remission in UC symptoms. Bowel movements and nocturnal episodes, along with the presence of blood and mucus in the stools were notably reduced or stopped.

Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *